Lorvotuzumab-MMAE (ADC)

描述	Lorvotuzumab-MMAE is an ADC consisting of an NCAM-directed antibody and Monomethyl auristatin E (MMAE) used for the study of multiple myeloma.
种属反应性	Human
状态	Liquid
浓度	1 mg/ml
纯度	>90% as determined by SEC.
克隆类型	Monoclonal
应用	Research Grade Biosimilar
靶标	NCAM
纯化方式	Purified by Ion Exchange Chromatography.
内毒素水平	Please contact with the lab for this information.
稳定性和存储	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
克隆号	Lorvotuzumab-MMAE
备注	For research use only. Not suitable for clinical or therapeutic use.

AntibodySystem Laboratories SAS was established in 2019 in France as an independent brand entity focused on the research, development, and production of protein and antibody reagents in the life sciences field. Our mission is to provide high-quality protein and antibody products to life science researchers worldwide. AntibodySystem's extensive product range includes traditional polyclonal antibodies, classic housekeeping antibodies, tag antibodies, high-activity proteins, in vivo functional antibodies, low-background flow cytometry antibodies, high-specificity nanobodies, specialized small molecule antibodies, premium phospho-specific antibodies, DNA/RNA antibodies, PEG antibodies, and more—spanning over ten product series.
Currently, AntibodySystem's product lines cover multiple research areas, including 48 types of viruses and superbugs, parasites, tumors, Alzheimer's disease, Parkinson's disease, hypersensitivity and allergic reactions, immune suppression, and immune activation.